Tachyon Therapeutics, Inc
Total Awards:
1
Award Value:
$7,141,843
Institution type:
For profit
Short Name:
Tachyon Therapeutics, Inc
Awards to the Institution
| Program | Investigator | Award Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Ivan King | TACH101: A Potent, First-In-Class KDM4 Inhibitor for Advanced Cancers | $7,141,843 |
Total: $7,141,843.00 |
